Miriam Rodriguez-Esquivel

Miriam Rodriguez-Esquivel

Auto-generated profile, based on publicly available information

Miriam Rodriguez-Esquivel

Oncology Genomics Biomedical Research Unit, Gynecology Pediatrics Hospital 3A, North Unity OOAD, Mexican Institute of Social Security, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Daniel Marrero-RodriguezDaniel Marrero-Rodriguez
Daniel Marrero-Rodriguez
KTKeiko Taniguchi-Ponciano
Keiko Taniguchi-Ponciano
MSMalayannan Subramaniam
Malayannan Subramaniam
John R. HawseJohn R. Hawse
John R. Hawse
KPKevin S. Pitel
Kevin S. Pitel
MSMauricio Salcedo
Mauricio Salcedo
Cervical cancer (CC) is associated with alterations in immune system balance, which is primarily due to a shift from Th1 to Th2 and the unbalance of Th17/Treg cells. Usingin silicoDNA copy number analysis, we have demonstrated that ~20% of CC samples exhibit gain of 8q22.3 and 19q13.31; the regions of the genome that encodes the KLF10 and PSG genes, respectively. Gene expression studies demonstrated that there were no alterations in KLF10 mRNA expression, whilst the PSG2 and −5 genes were up-regulated by 1.76 and 3.97-fold respectively in CC compared to normal tissue controls. siRNA and ChIP experiments in SiHa cells have demonstrated that KLF10 participates in immune response through regulation of IL6, IL25 and PSG2 and PSG5 genes. Using cervical tissues from KLF10−/−mice, we have identified down-regulation of PSG17, −21 and −23 and IL11. These results suggest that KLF10 may regulate immune system response genes in cervical cancer among other functions. KLF10 and PSG copy number variations and alterations in mRNA expression levels could represent novel molecular markers in CC.

1 January 2025 in Canadian Journal of Infectious Diseases and Medical Microbiology
Verified
Journal Article
Open access
VHVíctor Huerta-Padilla
Víctor Huerta-Padilla
Daniel Marrero-RodriguezDaniel Marrero-Rodriguez
Daniel Marrero-Rodriguez
KTKeiko Taniguchi-Ponciano
Keiko Taniguchi-Ponciano
ALAriana E. López
Ariana E. López
FCFernando Candanedo-González
Fernando Candanedo-González
MSMauricio Salcedo
Mauricio Salcedo
Cervical cancer (CC) is a public health concern related to the human papillomavirus (HPV) persistent infection. Minichromosome maintenance 2 (MCM2) has been postulated as a surrogate marker for HPV infection. Thymopoietin (TMPO) is a nuclear protein regulated by E2F such as MCM2 or p16. TMPO can give rise to six different isoforms. Herein, both the mRNA and protein levels of TMPO isoforms were analyzed in cervical cells. TMPO expression was selected and analyzed through in silico in several databases from the healthy cervix and cervical lesions. TMPO RNA expression was evaluated in cervical samples and cell lines by RT‐PCR and protein expression by Western‐blot and immunohistochemistry assays. TMPO and MCM2 immunostaining were evaluated in cervical smears. The clinical‐pathological correlation analysis was performed using Kruskal–Wallis or X 2 tests. TMPO is overexpressed in 74% of CC cells and all CC cell lines. Moreover, negative immunostaining was observed in normal cervical tissue, compared to strong expression for cervical lesions. Interestingly, TMPO‐α, ‐β, ‐δ, ‐ε, and ‐γ are expressed in all cervical cells and tissues, but a differential expression for α, ‐β, and ‐γ isoforms among the cervical cells was observed as overexpressed when HPV is present. Also, the immunostaining of both MCM2 and TMPO was quite similar, but TMPO expression was more sensitive and specific than MCM2 protein. The present study has revealed that TMPO protein expression could be a potential molecular marker for cervical transformed cells, highlighting the TMPO‐α, ‐β, and ‐γ isoforms as a promising molecular marker of HPV infection.

2 June 2021
Verified
Book Chapter
Open access
PDF file
MRMiriam Rodríguez-Esquivel
Miriam Rodríguez-Esquivel
JSJosé Alejandro Sánchez-Pérez
José Alejandro Sánchez-Pérez
HGHéctor Guerrero-Flores
Héctor Guerrero-Flores
ESEmmanuel Salcedo
Emmanuel Salcedo
TATeresa Apresa-García
Teresa Apresa-García
MSMauricio Salcedo
Mauricio Salcedo
The use of trained dogs for the detection of volatile biomarkers in biological samples has great potential to be used for non-invasive diagnosis and monitoring of several diseases such as cancer. It offers early, highly accurate detection with fast response times, non-invasive to patients and allows for repeated sampling. The aforementioned methods are useful as a portable technology to increase detection, screening, and monitoring coverage in populations at risk. In this sense, Cervical Cancer (CC) has become a public health concern of alarming proportions in many developing countries, particularly in low-income sectors and marginalized regions due to different factors that limit the coverage of screening methods and the acceptance rates of women attending their routine gynecological examination. As such, early detection is a crucial medical factor in improving not only their population’s quality of life but also its life expectancy. For the above, the great odor detection threshold exhibited by dogs is not unheard of and represents a potential opportunity to develop an affordable, accessible, and non-invasive method for detection of CC with high sensibility and specificity values.

1 January 2025 in Obstetrics and Gynecology International
Verified
Journal Article
Open access
RARodrigo Aldariz-Amaya
Rodrigo Aldariz-Amaya
MRMiriam Rodríguez-Esquivel
Miriam Rodríguez-Esquivel
ARAlfonso Ruiz-Romero
Alfonso Ruiz-Romero
FAFernanda Anthor
Fernanda Anthor
EMEmmanuel Mares
Emmanuel Mares
MSMauricio Salcedo
Mauricio Salcedo
Background: Human papillomavirus (HPV) is a major contributor to cervical cancer (CC), with Papanicolaou (Pap) smears and HPV testing serving as primary screening tools in developed countries. The effectiveness of these methods can vary based on a country’s epidemiological and socioeconomic context. This study introduces an innovative, noninvasive method employing surgical gauze worn as a feminine pad for HPV detection, with the aim of simplifying and improving screening processes. Materials and Methods: A total of 184 participants, including individuals classified as healthy, with cervical precursor lesions, or as with confirmed CC, were enrolled. All participants underwent cytological and colposcopic evaluations, with biopsies taken in cases of abnormal results. Each participant wore the device for 8 h, after which DNA was extracted from the soiled devices and analyzed via PCR for mitochondrial and HPV–DNA. Sensitivity and specificity were calculated to assess the effectiveness of HPV detection. Sensitivity and specificity values for HPV detection were obtained. Analysis of diagnostic tests was performed by OpenEpi software. Results: The device was well‐received, with high compliance among participants. PCR analysis revealed that 17.7% of healthy, 72.1% of precursor‐lesion cases, and 97.1% of CC cases tested positive for HPV. The calculated sensitivity and specificity for detecting high‐grade lesions (CIN2+ or CIN2/3 and CC) were 94.81% and 51.28%, respectively. For CC detection, sensitivity was 97.14% with a specificity of 54.39%. Conclusions: The use of this noninvasive device demonstrated a significant correlation with clinical outcomes, supporting its potential as an effective and accessible tool for HPV screening. This method offers a promising alternative to conventional screening techniques, particularly in settings where traditional methods face logistical and socioeconomic challenges.